FDA.reportPublic FDA data

Application 202853

Type
ANDA
Sponsor
PERRIGO ISRAEL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDESPRAY, METERED;NASAL0.665MG/SPRAYNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
45802-104olopatadine hydrochlorideOlopatadine HydrochloridePadagis Israel Pharmaceuticals LtdANDACurrent
45802-104olopatadine hydrochlorideOlopatadine HydrochloridePadagis Israel Pharmaceuticals LtdANDACurrent
45802-104olopatadine hydrochlorideOlopatadine HydrochloridePerrigo New York IncANDACurrent
45802-104olopatadine hydrochlorideOlopatadine HydrochloridePerrigo New York IncANDACurrent
63629-8434olopatadine hydrochlorideOlopatadine HydrochlorideBryant Ranch PrepackANDACurrent
63629-8434olopatadine hydrochlorideOlopatadine HydrochlorideBryant Ranch PrepackANDACurrent
63629-8434olopatadine hydrochlorideOlopatadine HydrochlorideBryant Ranch PrepackANDACurrent